EMSCULPT NEO builds off the legacy of its predecessor, EMSCULPT, by simultaneously emitting both radio frequency and high intensity electromagnetic energies.
The end result is more fat reduction and muscle growth, than any single gold standard product, for less time and less money.
Best of all, EMSCULPT NEO has broad appeal as it can treat patients up to BMI 35!
EMSCULPT NEO is based on an applicator simultaneously emitting synchronized RF and HIFEM+ energies.
Due to the radiofrequency heating, the muscle temperature quickly raises by several degrees. This prepares muscles for exposure to stress, similar to what a warm up activity does before any workout. In less than 4 minutes, the temperature in subcutaneous fat reaches levels that cause apoptosis, i.e. fat cells are permanently damaged and slowly removed from the body. Clinical studies showed on average a 30% reduction in subcutaneous fat.*
Bypassing the brain limitations, HIFEM+ energy contracts the muscle fibers in the area at intensities that are not achievable during voluntary workout. Extreme stress forces the muscle to adapt resulting in an increase in the number and growth of muscle fibers and cells. Clinical studies* showed on average a 25% growth in muscle volume.
Using the most reputable scientific methods, EMSCULPT NEO showed consistency in eliminating fat and building muscle. The data shown represents the average results of 3 EMSCULPT NEO’s clinical studies.* Results and patient experience may vary.
More Muscle*
On Average
Less Fat*
On Average
EMTONE simultaneously delivers both thermal and mechanical energy to treat all major contributing factors to cellulite.
Results and patient experience may vary. EMTONE is intended to provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. EMTONE massage device is intended to provide a temporary reduction in the appearance of cellulite. ©2019 BTL Group of Companies. All rights reserved. BTL® is registered trademark in the United States of America, the European Union, and other countries. The products, the methods of manufacture or the use may be subject to one or more U.S. or foreign patents or pending applications. Trademarks EMSCULPT®, EMSELLA®, EMTONE™, EMBODY®, and HIFEM® are parts of EM™ Family of products. *Data on file. The percentage indicates the level of difference of simultaneous application compared to the consecutive application